Meet with... Leaders from the National Cancer Institute's SBIR program

Aug 31 2016https://www.eventbrite.com/e/meet-with-leaders-from-the-national-cancer-institut...

The National Cancer Institute Small Business Innovation Research (NCI SBIR) Development Center is coming to JLABS @ LabCentral! Program directors Jonathan Franca-Koh and Christie Canaria will be presenting funding opportunities and other resources for startups in cancer technology. You will also learn about 15 new targeted funding opportunities in cancer detection, diagnosis and treatment in high priority areas of research for the NCI. Although the trends reflect improvements in cancer treatments and advances in technology have led to better tools for understanding, detecting and diagnosing cancer, we still have work to do. In 2016, an estimated 1,685,210 new cases of cancer will be diagnosed in the United States. The NCI is poised to reduce the burden of cancer in this country and around the world at an accelerated pace.

Program Overview:
NCI PRESENTS CURRENT AND NEW FUNDING OPPORTUNITIES
Program directors Jonathan Franca-Koh and Christie Canaria will discuss the exciting new non-dilutive targeted funding opportunities in cancer focused technology development. They will explain the application and review process at the NIH to help small businesses submit stronger applications. Additionally, the presentation will review the I-Corps at NIH program, other initiatives run by NCI to facilitate the success of SBIR companies, and the latest news regarding the Vice President's cancer initiative, the Cancer Moonshot.

Following the presentation, selected companies will have the opportunity to meet one-on-one with NCI. To be considered for a one-on-one meeting, please contact Christie Canaria, by Monday, August 22nd with your name, company name, and a short executive summary of your company as well as the technology project you would like to discuss with the NCI.


Agenda:
12:15 PM | Registration Opens
12:45 PM | Networking Lunch
1:30 PM | Presentation and Q&A
3:00 PM | Program Close
3:15-5:30 PM | One-on-one Meetings*

*Companies must have applied for a one-on-one meeting ahead of time and be approved. To be considered for a one-on-one meeting, please contact Christie Canaria, by August 22nd with your name, company name, and a short executive summary of your company as well as the technology project you would like to discuss with the NCI.


National Cancer Institute Participating Representatives:
Jonathan Franca-Koh | Program Director, SBIR Development Center, National Cancer Institute read bio»
Christie Canaria | Program Manager, SBIR Development Center, National Cancer Institute read bio»


About the National Cancer Institute:
The National Cancer Institute (NCI) is part of the National Institutes of Health (NIH), which is one of 11 agencies that compose the Department of Health and Human Services (HHS). The NCI, established under the National Cancer Institute Act of 1937, is the Federal Government's principal agency for cancer research and training. The National Cancer Act of 1971 broadened the scope and responsibilities of the NCI and created the National Cancer Program. Over the years, legislative amendments have maintained the NCI authorities and responsibilities and added new information dissemination mandates as well as a requirement to assess the incorporation of state-of-the-art cancer treatments into clinical practice. The National Cancer Institute coordinates the National Cancer Program, which conducts and supports research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients.
Connect with the NCI:   Connect on LinkedIn   Follow on Twitter


Fees:
Presentation & Lunch
$25 | General Public
$35 | General Public Onsite
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Registration to attend the presentation, Q&A, and lunch will remain open until Aug 30th (or sold out).

One-on-One Meeting
FREE | Application
FREE | Accepted Companies
Companies must have applied for a one-on-one meeting ahead of time and be approved. To be considered for a one-on-one meeting, please contact Christie Canaria, by August 22nd with your name, company name, and a short executive summary of your company as well as the technology project you would like to discuss with the NCI.


About the Meet with... Series:
The purpose of the Meet with Series events sponsored by JLABS is to help start-up entrepreneurs, as well as the academic community, connect with potential partners, such as big pharma or other investment corporations, through one-on-one meetings. It is also a chance for the featured corporation to outline their specific business development goals and clarify what types of products or research they are interested in and how best to approach them to get the partnering process started. Past participants include the Wellcome Trust, Bill & Melinda Gates Foundation, MedImmune Ventures, Mercury Fund, DARPA's Biological Technologies Office, Correlation Ventures, Breakout Labs, New Enterprise Associates, Canaan Partners, Thomas McNerney & Partners, NCI, NCATS, NINDS, Allegory Venture Partners, Clarus Ventures, Johnson & Johnson Innovation, Poliwogg, California Institute for Regenerative Medicine, Astellas Venture Management, and OrbiMed.


Venue:
JLABS @ LabCentral
700 Main Street
Cambridge, MA


National Cancer Institute Participating Representatives' Biographies:
Jonathan Franca-Koh | Program Director, SBIR Development Center, National Cancer Institute
Dr. Jonathan Franca-Koh is a Program Director at the National Cancer Institute's Small Business Innovation Research (SBIR) Development Center. Jonathan manages SBIR & STTR grants and contracts with a focus on cancer therapeutics and novel tools for research and drug discovery. He provides oversight throughout the award period and mentors applicants and awardees in developing their technology goals and commercialization strategy. Additionally, he plays an active role in several center initiatives, including recent investor forums, workshops, targeted funding opportunities, and represents the NCI on the trans-NIH REACH program. Prior to joining the SBIR Development Center, Jonathan was a Program Director at the NCI Division of Cancer Biology and Center for Strategic Scientific Initiatives, overseeing the Physical Sciences-Oncology Centers (PS-OC) program, a network of interdisciplinary centers that brought together physical scientists and cancer biologists. Jonathan received his PhD in Cell and Molecular Biology from the University of London's Institute of Cancer Research in 2003, and completed post-doctoral research at Johns Hopkins University and the J. Craig Venter Institute. In 2014 he completed his MBA from Johns Hopkins University, focusing on finance and health care innovation.



Christie Canaria, Ph.D. | Program Manager, SBIR Development Center, National Cancer Institute
Dr. Christie Canaria is a Program Manager in the Small Business Innovation Research (SBIR) Development Center at the National Cancer Institute (NCI). She provides programmatic support to small businesses applying to the SBIR and STTR programs and has areas of expertise in biological imaging, biosensors, and nanotechnology. Dr. Canaria is a central figure in planning special center initiatives, conducting outreach activities, and coordinating communications. In 2014, she played a leading role in launching the Innovation Corps (I-Corps™) at NIH Pilot, a program designed to support training to help project teams at NIH-funded small businesses overcome key obstacles along the path of innovation and commercialization.
In 2013, Dr. Canaria was awarded the AAAS Science & Technology Policy Fellowship and began science policy work in Washington, DC. Previously, she managed an optical microscopy facility at DOE Lawrence Berkeley National Laboratory as an imaging expert and neurobiologist; she was also a coordinator and imaging expert at the Caltech Biological Imaging Center where she developed advanced, multi-dimensional and time-lapse confocal imaging techniques. Dr. Canaria also worked in industry, expanding and optimizing surface chemistry and imaging processes for genome sequencing technologies. Dr. Canaria earned her Ph.D. in Chemistry from the California Institute of Technology and a B.S. in Chemistry from the University of California, San Diego.


Share